Pomalong 1mg capsules (Pomalidomide ) - MHP
POMALONG 1MG MULTIPLE MYELOMA DESCRIPTION Pomalidomide is sold under the brand name Pomalong 1mg and it belongs to anti-neoplastic drugs Pomalong 1mg is doable as orally bioavailable thalidomide derivative associated with numerous therapeutic activities such as: immune modulatory, anti-angiogenesis, anti-neoplastic. Pomalong 1mg combination with dexamethasone will cause liver injury CLINICAL USE The primary indication of Pomalong 1mg capsules treatment Multiple Myeloma condition. In this condition, Pomalong 1mg is used by combining with dexamethasone. Pomalong 1mg capsules are applicable in; Previously the Patients treated with two treatment such as proteasome inhibitor & Lenalidomide. Patients who are suffered with disease progression condition Pomalong 1mg treatment should be followed within 60 days in patients who are concluded the last treatment. MECHANISM OF ACTION Pomalong has three primary pharmacological activities against cancer cel...